The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.
Nasdaq: KERX
Change
symbol:
     
 PROFILE
Keryx wants cells to get the right message. The firm (whose name is from the Greek word for "messenger") uses proprietary technology and genomic data to target diseases related to the malfunction of kinases -- enzymes that control communication between cells. It has identified about a dozen compounds targeting cancer, metabolic, and cardiovascular diseases, among others. Its lead in-house candidate is KRX 123, targeting prostate cancer. Keryx has licensed KRX 101 (used to treat vascular disease) to develop as a therapy for diabetes-related kidney disease. Partners include Novo Nordisk and the Hebrew University of Jerusalem. Investor Lindsay Rosenwald owns more than 30% of the firm through Paramount Capital.

 COMPETITION
Ligand Pharmaceuticals Incorporated (LGND)
Novartis AG (NVS)
Vertex Pharmaceuticals Incorporated (VRTX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 36
Revenue per employee: $2,777.78

 KEY PEOPLE
• Morris Laster
    CEO
• Robert E. Gallahue
    CFO

 CONTACT INFO
5 Kiryat Mada
Jerusalem 91236, Israel
Phone: 972-2-541-2700
Fax: 972-2-541-2701
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001